Literature DB >> 20417672

Identification of cellular proteins interacting with equine infectious anemia virus S2 protein.

Lina Covaleda1, Bich-Ty Gno, Fredrick J Fuller, Susan L Payne.   

Abstract

The macrophage-tropic lentivirus, equine infectious anemia virus (EIAV), encodes the small auxiliary protein S2 from a short open reading frame that overlaps the amino terminus of env EIAV S2 is dispensable for virus replication in cultured cells but is required for disease production. S2 is approximately 7 kDa and has no overall amino acid sequence homology to other cellular or viral proteins. Therefore it is likely that S2 plays a role as an adaptor protein. To further investigate S2 function we performed a yeast-2-hybrid screen to identify cellular proteins that interact with EIAV S2. The screen identified two human cellular proteins, amplified in osteosarcoma (OS-9) and proteasome 26S ATPase subunit 3 (PSMC3) that interact with S2. The equine homologues of these proteins were cloned and their interactions with S2 confirmed using co-immunoprecipitation assays. We identified two OS-9 isoforms that interact with S2 and a third splice variant that does not, indicating a region of OS-9 apparently required for the S2 interaction. The roles of these cellular proteins during EIAV infection have not been determined. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417672      PMCID: PMC2897910          DOI: 10.1016/j.virusres.2010.04.007

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  27 in total

1.  A selective interaction between OS-9 and the carboxyl-terminal tail of meprin beta.

Authors:  Larisa Litovchick; Elena Friedmann; Shmuel Shaltiel
Journal:  J Biol Chem       Date:  2002-07-01       Impact factor: 5.157

2.  The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.

Authors:  F Li; C Leroux; J K Craigo; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator.

Authors:  P Nelbock; P J Dillon; A Perkins; C A Rosen
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

5.  HBV X protein targets HIV Tat-binding protein 1.

Authors:  O Barak; A Aronheim; Y Shaul
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

Review 6.  Molecular basis of the pathobiology of lentiviruses.

Authors:  J E Clements; S L Payne
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

7.  Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein.

Authors:  Paul G Corn; E Robert McDonald; James G Herman; Wafik S El-Deiry
Journal:  Nat Genet       Date:  2003-10-12       Impact factor: 38.330

8.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

9.  Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.

Authors:  R L Schiltz; D S Shih; S Rasty; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  Complete sequence analysis of a gene (OS-9) ubiquitously expressed in human tissues and amplified in sarcomas.

Authors:  Y A Su; C M Hutter; J M Trent; P S Meltzer
Journal:  Mol Carcinog       Date:  1996-04       Impact factor: 4.784

View more
  4 in total

1.  TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.

Authors:  Minghua Li; Abdul A Waheed; Jingyou Yu; Cong Zeng; Hui-Yu Chen; Yi-Min Zheng; Amin Feizpour; Björn M Reinhard; Suryaram Gummuluru; Steven Lin; Eric O Freed; Shan-Lu Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-06       Impact factor: 11.205

2.  S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.

Authors:  Ajit Chande; Emilia Cristiana Cuccurullo; Annachiara Rosa; Serena Ziglio; Susan Carpenter; Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-01       Impact factor: 11.205

3.  A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses.

Authors:  Xue-Feng Wang; Shuai Wang; Qiang Liu; Yue-Zhi Lin; Cheng Du; Yan-Dong Tang; Lei Na; Xiaojun Wang; Jian-Hua Zhou
Journal:  Viruses       Date:  2014-11-10       Impact factor: 5.048

4.  Bcl-2-associated transcription factor 1 interacts with fragile X-related protein 1.

Authors:  Yun Ma; Changbo Wang; Binyuan Li; Lingxue Qin; Jiao Su; Manjun Yang; Shuya He
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.